Baxter International Inc. BAX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score

43/100

2/7 Pass

SharesGrow Intrinsic Value

Baxter International Inc. (BAX) has 20 ज्ञात अंदरूनी और संस्थागत धारक रिकॉर्ड पर. सबसे बड़े धारक हैं Third Point LLC के साथ 23,008,125 शेयर. अन्य उल्लेखनीय धारकों में शामिल हैं Hider Andrew P. और Grade Joel T..

पिछले 12 महीनों में, अंदरूनी लोगों ने किए हैं 40 लेनदेन BAX स्टॉक — 18 खरीद (मूल्य $14.55M) और 0 बिक्री (मूल्य RSU पुरस्कार). अंदरूनी खरीदारी ने बिक्री को पीछे छोड़ दिया है, जो कंपनी की संभावनाओं में विश्वास का संकेत हो सकता है.

BAX इनसाइडर होल्डिंग

शीर्ष धारक

Third Point LLC

23,008,125 शेयर

खरीद (12 माह)

$14.55M मूल्य

बिक्री (12 माह)

$0.00 मूल्य

12-माह लेनदेन गतिविधि

खरीदें 45%

बेचें 0%

शीर्ष इनसाइडर धारक

#	नाम	भूमिका	स्वामित्व वाले शेयर	अंतिम दाखिल तिथि	सापेक्ष आकार
1	Third Point Llc	Director	23,008,125	2019-05-17	100%
2	Hider Andrew P.	President and CEO	488,506	2026-03-03	2%
3	Grade Joel T.	EVP and CFO	271,674	2026-03-10	1%
4	Almeida Jose E	Chairman, CEO, President	243,589	2024-12-17	1%
5	Mason Jeanne K	EVP, Chief HR Officer	199,853	2025-12-16	1%
6	Saccaro James	EVP, Chief Financial Officer	177,899	2023-03-06	1%
7	Rosenbloom David S.	EVP and General Counsel	138,216	2026-03-10	1%
8	Sonig Alok	EVP,group President,pharma	128,219	2025-09-04	1%
9	Rasul Reazur	EVP,group Pres,healthcare	125,557	2026-03-10	1%
10	Knight Heather	EVP, Chief Operating Officer	118,934	2025-03-10	1%
11	Scharf David P.	CVP and General Counsel	109,789	2017-02-23	0%
12	Toth Christopher A.	EVP, Group Pres, Kidney Care	105,186	2025-02-04	0%
13	Franzi Cristiano	SVP, President, Emea	102,145	2023-03-06	0%
14	Soriano Maria Cecilia	Group Pres., Itt & Pharma.	75,045	2026-03-10	0%
15	Borzi James W	EVP,chief Supply Chain Officer	71,948	2025-09-04	0%
16	Eyre Brik V	SVP, President, Americas	68,587	2019-03-04	0%
17	Stevens Brian	SVP, CAO & Controller	67,538	2024-03-08	0%
18	Shafer David Brent	Other: Chair of the Board	59,446	2025-08-21	0%
19	Accogli Giuseppe	EVP, Chief Operating Officer	55,126	2022-03-04	0%
20	Martin Sean	SVP and General Counsel	52,632	2022-03-04	0%

हालिया लेनदेन (पिछले 12 माह)

तिथि	नाम	भूमिका	प्रकार	शेयर	मूल्य	मूल्य
2026-03-06	Soriano Maria Cecilia	Group Pres., Itt & Pharma.	RSU कर रोक	2,848	$17.69	$50.38K
2026-03-06	Rasul Reazur	EVP,group Pres,healthcare	RSU कर रोक	12,674	$17.69	$224.2K
2026-03-06	Rosenbloom David S.	EVP and General Counsel	RSU कर रोक	6,620	$17.69	$117.11K
2026-03-06	Zielinski Anita A	SVP, CAO and Controller	RSU कर रोक	1,932	$17.69	$34.18K
2026-03-06	Grade Joel T.	EVP and CFO	RSU कर रोक	8,153	$17.69	$144.23K
2026-03-02	Soriano Maria Cecilia	Group Pres., Itt & Pharma.	RSU कर रोक	1,852	$19.69	$36.47K
2026-02-27	Soriano Maria Cecilia	Group Pres., Itt & Pharma.	RSU पुरस्कार	57,471	$20.37	$1.17M
2026-02-27	Carlisle Cynthia	Executive Vice President, Chro	RSU पुरस्कार	17,806	-	-
2026-02-23	Carlisle Cynthia	Executive Vice President, Chro	अज्ञात	-	-	-
2026-03-02	Rasul Reazur	EVP,group Pres,healthcare	RSU कर रोक	1,614	$19.69	$31.78K
2026-02-27	Hider Andrew P.	President and CEO	RSU पुरस्कार	488,506	$20.37	$9.95M
2026-03-02	Rosenbloom David S.	EVP and General Counsel	RSU कर रोक	1,336	$19.69	$26.31K
2026-02-27	Rosenbloom David S.	EVP and General Counsel	RSU पुरस्कार	64,655	$20.37	$1.32M
2026-02-27	Zielinski Anita A	SVP, CAO and Controller	RSU पुरस्कार	30,864	-	-
2026-02-27	Grade Joel T.	EVP and CFO	RSU पुरस्कार	103,448	$20.37	$2.11M
2026-02-13	Mcdonnell Michael R.	Director	RSU पुरस्कार	1,811	-	-
2026-02-13	Mcdonnell Michael R.	Director	अज्ञात	-	-	-
2026-02-09	Soriano Maria Cecilia	Group Pres., Itt & Pharma.	RSU कर रोक	918	$21.73	$19.95K
2026-02-09	Rasul Reazur	EVP,group Pres,healthcare	RSU कर रोक	5,770	$21.73	$125.38K
2026-02-09	Rosenbloom David S.	EVP and General Counsel	RSU कर रोक	5,225	$21.73	$113.54K
2026-02-09	Grade Joel T.	EVP and CFO	RSU कर रोक	9,144	$21.73	$198.7K
2025-12-12	Mason Jeanne K	EVP, Chief HR Officer	RSU कर रोक	650	$19.15	$12.45K
2025-12-01	Soriano Maria Cecilia	Group Pres., Itt & Pharma.	अज्ञात	23,787	$35.44	$843.01K
2025-12-01	Grade Joel T.	EVP and CFO	RSU कर रोक	8,288	$19.08	$158.14K
2025-09-02	Sonig Alok	EVP,group President,pharma	RSU कर रोक	3,191	$24.17	$77.13K